Corium Announces Issuance of Key U.S. Patent Covering Corplex™ Donepezil Transdermal System for Alzheimer’s Disease
13 juin 2018 07h30 HE
|
Corium International, Inc.
MENLO PARK, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present at the Jefferies 2018 Global Healthcare Conference
24 mai 2018 08h00 HE
|
Corium International, Inc.
MENLO PARK, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Second Quarter Fiscal 2018 Financial Results and Corporate Highlights
14 mai 2018 16h01 HE
|
Corium International, Inc.
MENLO PARK, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Second Quarter Fiscal 2018 Financial Results on Monday, May 14, 2018
08 mai 2018 08h00 HE
|
Corium International, Inc.
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the second quarter ended March 31, 2018...
Corium to Present at the 17th Annual Needham Healthcare Conference
19 mars 2018 08h00 HE
|
Corium International, Inc.
MENLO PARK, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Prices Offering of $100 Million of 5% Convertible Senior Notes
01 mars 2018 08h35 HE
|
Corium International, Inc.
MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study
28 févr. 2018 16h15 HE
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights
08 févr. 2018 16h03 HE
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present at Upcoming Healthcare Investor Conferences
06 févr. 2018 08h00 HE
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018
01 févr. 2018 16h05 HE
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the first quarter ended December 31, 2017...